Mixed Small Cell Neuroendocrine Carcinoma And Adenocarcinoma Of The Gallbladder: A Case Report

Junping Pan,Jun Wang,Guang Zhou,Xiaojin He,Xinhua Zhu,Xiaolei Shi,Yafu Wu,Yitao Ding
2018-01-01
Abstract:Objective: To investigate the clinical features and treatment options of mixed small cell neuroendocrine carcinoma and adenocarcinoma of the gallbladder. Methods: Gallbladder small cell carcinoma comprises only 0.5% of all gallbladder cancer. It is composed of invasive tumors and the effect of existing treatments is poor. Here, we report a case of small cell neuroendocrine carcinoma with a mixed gallbladder adenocarcinoma. Results: There were no specific symptoms or abnormal blood test results in this case. Imaging examinations indicated that an intraluminal mass in the gallbladder was accompanied by multiple microlithiasis, and the lymph node was enlarged in the hepatic hilum. The mass then oppressed the bile duct, and jaundice appeared. Radical hepatopancreaticoduodenectomy (HPD) was performed. Pathological diagnosis was a mixture of small cell neuroendocrine carcinoma (65%) and adenocarcinoma (35%) of the gallbladder. The TNM stage was IVB, T3N2M0. Four courses of postoperative chemotherapy were carried. Twenty-five weeks after surgery, brain metastasis appeared, and local palliative three-dimensional adaptive radiotherapy was performed. The patient died 28 weeks after surgery. Conclusion: Gallbladder small cell neuroendocrine carcinoma (SCNEC) is a highly malignant disease. Radical surgery and other comprehensive treatment with combinational chemotherapy might improve the prognosis.
What problem does this paper attempt to address?